Therapeutic hypothermia (TH) has revolutionized the management of neonates suffering from hypoxic-ischemic encephalopathy (HIE), offering a neuroprotective strategy that substantially…

While the FDA mulls whether to approve Protagonist Therapeutics’ hematology asset, the biotech is thinking it will pocket $400 million…

In a groundbreaking study set to reshape our understanding of bone biology, researchers have uncovered a pivotal role for osteocytic…

In a groundbreaking study published in Nature Communications, researchers have unveiled a novel molecular mechanism by which the enzyme dual-specificity…

Per- and polyfluoroalkyl substances, commonly known as PFAS or ‘forever chemicals,’ have long captured the attention of environmental scientists and…

The construction industry accounts for an astonishing 37 percent of global CO2 emissions, positioning it as a critical sector in…

As the incidence of early-onset cardiovascular disease escalates across the globe, a lesser-explored dimension of this emerging health crisis is…

Coral reefs represent some of the most biologically rich ecosystems on our planet, occupying less than one percent of the…

Accent Therapeutics has halted work on a solid tumor drug due to adverse events in a phase 1/2 study. The…

In the rapidly evolving landscape of diabetes treatment, tirzepatide has emerged as a novel and potent therapeutic agent, heralded for…